We are live on ! Find out more
ARCT icon

Arcturus Therapeutics
ARCT

156 hedge funds and large institutions have $909M invested in Arcturus Therapeutics in 2021 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 48 increasing their positions, 42 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

113% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 16

65% more call options, than puts

Call options by funds: $22.8M | Put options by funds: $13.8M

31% more capital invested

Capital invested by funds: $694M → $909M (+$215M)

14% more repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 42

12% more funds holding

Funds holding: 139 → 156 (+17)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

5.5% less ownership

Funds ownership: 77.91% → 72.41% (-5.5%)

Holders
156
Holders Change
+17
Holders Change %
+12.23%
% of All Funds
2.73%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
34
Increased
48
Reduced
42
Closed
16
Calls
$22.8M
Puts
$13.8M
Net Calls
+$8.98M
Net Calls Change
+$10.8M

Top Buyers

1
Fidelity Investments
Fidelity Investments
Massachusetts
+$15.4M
2
NAMA
Nikko Asset Management Americas
New York
+$6.44M
3
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group
Japan
+$6.44M
4
Millennium Management
Millennium Management
New York
+$3.99M
5
IHAM
Integral Health Asset Management
New York
+$3.81M

Top Sellers

1
O
OrbiMed
New York
-$28.7M
2
AIM
ARK Investment Management
Florida
-$15.9M
3
Two Sigma Investments
Two Sigma Investments
New York
-$14.3M
4
State Street
State Street
Massachusetts
-$12.8M
5
Two Sigma Advisers
Two Sigma Advisers
New York
-$10.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
ACM
26
Altium Capital Management
New York
$3.82M +$3.58M +80,000 New
RA
27
Royce & Associates
New York
$3.81M – – –
Connor, Clark & Lunn Investment Management (CC&L)
28
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$3.73M +$3.5M +78,082 New
Bank of New York Mellon
29
Bank of New York Mellon
New York
$3.67M +$269K +6,008 +8%
GIM
30
Granahan Investment Management
Massachusetts
$3.5M +$3.28M +73,177 New
Citadel Advisors
31
Citadel Advisors
Florida
$3.43M +$3.21M +71,737 New
Citigroup
32
Citigroup
New York
$3.09M -$3.53M -78,871 -55%
PAMS
33
Pictet Asset Management (Switzerland)
Switzerland
$2.91M +$2.73M +60,930 New
JAMONY
34
Jacob Asset Management of New York
California
$2.68M +$231K +5,155 +10%
Jane Street
35
Jane Street
New York
$2.64M +$1.33M +29,748 +116%
PP
36
PDT Partners
New York
$2.37M +$2.22M +49,500 New
Voloridge Investment Management
37
Voloridge Investment Management
Florida
$2.3M -$7.56M -168,762 -78%
SCM
38
Shelton Capital Management
Colorado
$2.29M +$448K +10,000 +26%
Swiss National Bank
39
Swiss National Bank
Switzerland
$2.21M – – –
KOC
40
Koss-Olinger Consulting
Florida
$2.09M -$672K -15,000 -26%
Vontobel Holding
41
Vontobel Holding
Switzerland
$1.92M +$45.5K +1,015 +3%
MWNA
42
Marshall Wace North America
New York
$1.91M +$1.79M +39,972 New
BG
43
Bellevue Group
Switzerland
$1.65M +$1.55M +34,500 New
State of Wisconsin Investment Board
44
State of Wisconsin Investment Board
Wisconsin
$1.63M +$309K +6,900 +25%
AA
45
ALPS Advisors
Colorado
$1.54M -$108K -2,406 -7%
SCA
46
Snowden Capital Advisors
New York
$1.53M +$4.75K +106 +0.3%
HWAM
47
Hennion & Walsh Asset Management
New Jersey
$1.43M +$460K +10,276 +52%
RhumbLine Advisers
48
RhumbLine Advisers
Massachusetts
$1.42M +$43.7K +975 +3%
California State Teachers Retirement System (CalSTRS)
49
California State Teachers Retirement System (CalSTRS)
California
$1.37M -$21.6K -483 -2%
PIM
50
Platinum Investment Management
Australia
$1.35M – – –
1
2
3 4 5

ARCT Hedge Fund Activity: Q3 2021 in Review

156 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Arcturus Therapeutics (ARCT) for Q3 2021, worth a combined $909M — up 31% from $694M a quarter earlier.

Buyers outnumbered sellers: 34 funds opened new ARCT positions and 16 closed out — a net gain of 18 holders — while 48 added to existing stakes and 42 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $15.4M. The largest seller was OrbiMed, exiting entirely with an estimated $28.7M sold.

  • 156 institutional investors held Arcturus Therapeutics (ARCT) as of Q3 2021, up from 139 in Q2 2021.
  • Funds reported $909M of Arcturus Therapeutics stock for Q3 2021, up 31% quarter-over-quarter.
  • 34 funds opened new Arcturus Therapeutics positions in Q3 2021 and 16 closed out, a net change of +18 holders.
  • The largest Arcturus Therapeutics buyer in Q3 2021 was Fidelity Investments, an estimated $15.4M added.
  • The largest Arcturus Therapeutics seller in Q3 2021 was OrbiMed, an estimated $28.7M sold.

Based on aggregated 13F filings for Q3 2021.